" class="no-js "lang="en-US"> Thomas Schinecker Archives - Medtech Alert
Thursday, March 30, 2023

Sort by:


Top Post

NHS Slashes Longest Elective and Cancer Patient Waiting Lists

The number of people waiting over 18 months for NHS care has fallen again despite […]

Roche Launches New BenchMark ULTRA PLUS System for Cancer Diagnostics Enabling Timely, Targeted Patient Care

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the BenchMark ULTRA PLUS system, its […]

Roche Launches Human Papillomavirus (HPV) Self-sampling Solution, Expanding Cervical Cancer Screening Options

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of a human papillomavirus (HPV) […]

Roche Develops Unique PCR Tests to Detect the Monkeypox Virus

Roche (SIX: RO, ROG; OTCQX: RHHBY) and its subsidiary TIB Molbiol have developed three unique LightMix® Modular Virus […]

Roche Enters Partnership With the Global Fund to Support Low- and Middle-income Countries in Strengthening Critical Diagnostics Infrastructure

Roche (SIX: RO, ROG; OTCQX: RHHBY), through its Global Access Program, and The Global Fund […]

Roche Provides Molecular Testing Solutions to Identify and Differentiate SARS-CoV-2 Omicron Variants of Concern

Roche (SIX: RO, ROG; OTCQX: RHHBY) and TIB Molbiol, a subsidiary within the Roche Diagnostics division, […]

Significant Investment Accelerates Freenome's Multiomics Platform for the Early Detection of Cancer

Freenome, a privately held biotech company, announced today that Roche has made an investment of $290 […]

  1. Nanoscope Therapeutics Announces Positive Topline Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa Read more
  2. Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Read more
  3. Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Read more
  4. Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Read more
  5. Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Read more